- Email: [email protected]
Subject Index Volume 147
Journal of Controlled Release 147 (2010) e11–e13
Contents lists available at ScienceDirect
Journal of Controlled Release j o u r n a l h o m e p a g e : w w w. e l s ev i e r. c o m / l o c a t e / j c o n r e l
Subject Index Volume 147 (2010) Acid sphingomyelinase, (147) 171 Adipose tissue, (147) 261 Adjuvant, (147) 211 Adjuvants, (147) 342 Administration routes, (147) 342 ALE, (147) 232 Alginate, (147) 193 Amphiphilic polymers, (147) 289 Angiogenesis, (147) 30 Angiopep-2, (147) 118 Antibodies, (147) 342 Anticancer drug, (147) 144 Anti-cancer effect, (147) 420 Anti-inflammatory activity, (147) 127 Apoptosis, (147) 76, (147) 101, (147) 246, (147) 278 Approaches, (147) 314 Asymmetric bilayer membrane, (147) 413 Bcl-xL, (147) 76 Beclomethasone dipropionate, (147) 127 Bioactivity, (147) 38 Biodegradable polymer networks, (147) 54 Biodistributions, (147) 253 Biomedical materials, (147) 298 Biomolecules, (147) 413 Bioneedle, (147) 211 Bisphosphonate, (147) 45 Block copolymer, (147) 428 Block-copolymer, (147) 92 BMP-2, (147) 38, (147) 92 Brain targeting, (147) 118 Büchi, (147) 304 Calcium phosphate, (147) 45 Cancer, (147) 154 Cancer cell, (147) 101 Cancer drug delivery, (147) 350 Carbonate apatite, (147) 101 Carrier-cell interaction, (147) 127 Caspase, (147) 246, (147) 278 Cationic amphiphiles, (147) 246 Cationic carriers, (147) 385 Cell-penetrating peptide, (147) 171 Cellular uptake, (147) 109 Ceramide, (147) 171 Chitosan, (147) 109 Chitosan hydrogel, (147) 38 Chondrogenesis, (147) 84 Chondroitinase, (147) 24
doi:10.1016/S0168-3659(10)00837-0
Chronopharmaceutical technology, (147) 314 Circadian rhythm, (147) 314 cis-bis(cyclohexylamine)dinitratoplatinum, (147) 144 Coaxial system, (147) 193 Compaction of pellets, (147) 2 Confocal laser scanning microscopy, (147) 218 Confocal microscopy, (147) 202 Conjugation, (147) 84 Controlled release, (147) 24, (147) 30, (147) 428 Core–shell microcapsule, (147) 193 Cornea, (147) 76 Cutaneous leishmaniasis, (147) 368 Cyclin B1, (147) 101 Cyclodextrin, (147) 377 Cyclotriphosphazene, (147) 144 Cytokines, (147) 342 Delivery, (147) 385 Dexamethasone phosphate, (147) 225 Diabetes, (147) 377 Direct translocation, (147) 171 Dissolution, (147) 232 Docetaxel, (147) 278 Dose sparing, (147) 326 Doxorubicin, (147) 428 Drug delivery, (147) 171, (147) 253, (147) 298, (147) 408, (147) 428, (147) 436 Drug distribution, (147) 92 Drug release, (147) 392 Drug targeting, (147) 136 Dual GF release, (147) 180 Dual growth factor delivery, (147) 193 Ectopic bone formation, (147) 38 Efflux pumps, (147) 62 Encapsulation efficiency, (147) 413 Endocytosis, (147) 261 Endotoxic shock, (147) 17 Enteric coatings, (147) 242 Enteric polymers, (147) 242 Erosion, (147) 70 Eye drop, (147) 76 Fibrin, (147) 24, (147) 180 Fibrosis, (147) 400 Fibrous capsule, (147) 400 Foreign body reaction, (147) 400 Formulation, (147) 211 Formulation pH, (147) 38
e12
Freeze drying, (147) 211 Fumaric acid monoethyl ester, (147) 54 Fusion protein, (147) 17 β-galactosidase, (147) 187 Gamma camera, (147) 253 Gamma scintigraphy, (147) 70, (147) 242 Gastric resistance, (147) 242 Gastrointestinal transit, (147) 242 Gelatin, (147) 269 Gene delivery, (147) 154, (147) 246 Gene silencing, (147) 101 Gemcitabine, (147) 163 Glycosaminoglycan, (147) 24 Gold nanoparticle, (147) 136 Heparin, (147) 420 Hepatitis B surface antigen, (147) 211 Human adipose-derived stem cell, (147) 84 Human growth hormone (hGH), (147) 359 Human serum albumin, (147) 17 Hyaluronan hydrogel, (147) 38 Hydrogel, (147) 377 Hydrogels, (147) 298 Hydroxyapatite, (147) 278 Hydroxypropylmethylcellulose (HPMC), (147) 70 Hyperthermia, (147) 436 Immune-response modifiers, (147) 342 Implant, (147) 400 In situ forming implant, (147) 350 In vivo drug release, (147) 350 In vivo visualisation, (147) 218 Influenza, (147) 326 Intracellular delivery, (147) 420 Intracellular uptake, (147) 261 In-vitro/in-vivo correlation (IVIVC), (147) 70 Labelling, (147) 92 Lactose intolerance, (147) 187 Ligand targeting, (147) 261 Lipid microspheres, (147) 202 Lipoplexes, (147) 385 Liposome, (147) 136 Liposomes, (147) 342 Local delivery, (147) 400 LRP, (147) 118 Macrophage, (147) 408 Mathematical modelling, (147) 232 Mesenchymal stem cells, (147) 154 Metabolization, (147) 163 Methacrylic acid ethyl acrylate copolymer, (147) 242 Micelle, (147) 144 Microneedle, (147) 326 Microneedles, (147) 218 Microparticles, (147) 187, (147) 377 Microsphere, (147) 45 Microspheres, (147) 92, (147) 342 Mouse model, (147) 342 MRI, (147) 232 mRNA, (147) 385 mTOR siRNA, (147) 400 Multiple-unit pellet system, (147) 2 MUPS, (147) 2 Myocardial infarction, (147) 30
Subject Index Volume 147 (2010)
NAcHis-GC, (147) 253 Nano-crystals, (147) 304 Nano-emulsion, (147) 304 Nanogel, (147) 420 Nanomedicine, (147) 408 Nanoparticle, (147) 163, (147) 278, (147) 304, (147) 408 Nanoparticles, (147) 342 Nanostructure, (147) 392 Near-infrared fluorescence, (147) 253 Nona-arginine, (147) 171 Non-invasive imaging, (147) 253 Non-ionic surfactant vesicles, (147) 127 N-vinyl-2-pyrrolidone, (147) 54 Ocular iontophoresis, (147) 225 Optical coherence tomography, (147) 333 Oral insulin, (147) 377 Oral peptide delivery, (147) 289 Osteoclast differentiation, (147) 45 Osteoporosis, (147) 45 Particle distribution, (147) 202 PDGF-BB, (147) 180 PEG, (147) 62, (147) 180 PEG-PLGA, (147) 92 PEI, (147) 62 Pellets, (147) 2 Peptidase inhibition, (147) 289 Peptide, (147) 392 Peptide modified nanocarrier, (147) 261 Percolation threshold, (147) 70 P-glycoprotein, (147) 62, (147) 118 Phagocytosis, (147) 408 Pharmacokinetic, (147) 17 Pharmacodynamic, (147) 17 Phase inversion, (147) 350 Phase transition, (147) 136 Phase-guided assembly, (147) 413 Phosphatidyloligoglycerol, (147) 436 Photo-crosslinking kinetics, (147) 54 Photodynamic therapy, (147) 368 pH-sensitive polymers, (147) 242 Physical cross-linking, (147) 298 Platinum drug, (147) 144 PLGA, (147) 187, (147) 193 PLGA microparticles, (147) 30 Pluronic, (147) 420 Pluronic F127, (147) 84 Pluronic-based nano-carriers, (147) 109 Poly(allyl)amine, (147) 289 Polycation, (147) 359 Polyelectrolyte complex (PEC), (147) 359 Polyethylene glycol, (147) 269 Polyethylene oxide, (147) 232 Polymeric micelle, (147) 76 Polymeric micelles, (147) 118 Polymeric microneedle arrays, (147) 333 Polymersome, (147) 413, (147) 428 Polyplexes, (147) 385 Poly(trimethylene carbonate), (147) 54 Pore formation, (147) 246 Primary human lung fibroblasts, (147) 127 Prostate cancer, (147) 278 Protein release, (147) 202 Pulmonary drug carrier, (147) 127 Pulsatile drug delivery, (147) 314
Subject Index Volume 147 (2010
Recumbinant albumin, (147) 17 Release mechanism, (147) 202 Resistance, (147) 163 RNase A, (147) 420 Salmon calcitonin, (147) 289 SAXS, (147) 136 Scaffold, (147) 392 Self-assembly, (147) 392 siRNA, (147) 101 Skin, (147) 326 Spinal cord, (147) 24 Spray drying, (147) 304 Squalenoylation, (147) 163 Stability, (147) 211 Stem cells, (147) 193 Stimuli, (147) 314 Subcellular localization, (147) 163 Sustained protein delivery, (147) 359 Tableting of pellets, (147) 2 Targeting, (147) 154, (147) 187 TGF-β1, (147) 180 TGF-β1 release, (147) 84 Thermoresponsive, (147) 298 Thermosensitive hydrogel, (147) 359 Thermosensitive liposomes, (147) 436
γ-thiobutyrolactone, (147) 62 Thiomers, (147) 62 Thioredoxin, (147) 17 Thrombolytic therapy, (147) 269 Timolol, (147) 225 t-PA, (147) 269 Transcutaneous, (147) 368 Transport, (147) 218 Trans-scleral, (147) 225 Tumor cell lines, (147) 246 Tumor targeting, (147) 109 Ultradeformable liposomes, (147) 368 Ultrasound, (147) 269, (147) 350 UV light, (147) 136 Vaccine delivery, (147) 342 Vancomycin, (147) 225 Vascular, (147) 180 VEGF, (147) 30 Vehicle, (147) 154 Vesicle, (147) 428 Vesicle size, (147) 436 Vinyl acetate, (147) 54 Virus-like particle vaccine, (147) 326 WGA, (147) 187
e13
Contents lists available at ScienceDirect
Journal of Controlled Release j o u r n a l h o m e p a g e : w w w. e l s ev i e r. c o m / l o c a t e / j c o n r e l
Subject Index Volume 147 (2010) Acid sphingomyelinase, (147) 171 Adipose tissue, (147) 261 Adjuvant, (147) 211 Adjuvants, (147) 342 Administration routes, (147) 342 ALE, (147) 232 Alginate, (147) 193 Amphiphilic polymers, (147) 289 Angiogenesis, (147) 30 Angiopep-2, (147) 118 Antibodies, (147) 342 Anticancer drug, (147) 144 Anti-cancer effect, (147) 420 Anti-inflammatory activity, (147) 127 Apoptosis, (147) 76, (147) 101, (147) 246, (147) 278 Approaches, (147) 314 Asymmetric bilayer membrane, (147) 413 Bcl-xL, (147) 76 Beclomethasone dipropionate, (147) 127 Bioactivity, (147) 38 Biodegradable polymer networks, (147) 54 Biodistributions, (147) 253 Biomedical materials, (147) 298 Biomolecules, (147) 413 Bioneedle, (147) 211 Bisphosphonate, (147) 45 Block copolymer, (147) 428 Block-copolymer, (147) 92 BMP-2, (147) 38, (147) 92 Brain targeting, (147) 118 Büchi, (147) 304 Calcium phosphate, (147) 45 Cancer, (147) 154 Cancer cell, (147) 101 Cancer drug delivery, (147) 350 Carbonate apatite, (147) 101 Carrier-cell interaction, (147) 127 Caspase, (147) 246, (147) 278 Cationic amphiphiles, (147) 246 Cationic carriers, (147) 385 Cell-penetrating peptide, (147) 171 Cellular uptake, (147) 109 Ceramide, (147) 171 Chitosan, (147) 109 Chitosan hydrogel, (147) 38 Chondrogenesis, (147) 84 Chondroitinase, (147) 24
doi:10.1016/S0168-3659(10)00837-0
Chronopharmaceutical technology, (147) 314 Circadian rhythm, (147) 314 cis-bis(cyclohexylamine)dinitratoplatinum, (147) 144 Coaxial system, (147) 193 Compaction of pellets, (147) 2 Confocal laser scanning microscopy, (147) 218 Confocal microscopy, (147) 202 Conjugation, (147) 84 Controlled release, (147) 24, (147) 30, (147) 428 Core–shell microcapsule, (147) 193 Cornea, (147) 76 Cutaneous leishmaniasis, (147) 368 Cyclin B1, (147) 101 Cyclodextrin, (147) 377 Cyclotriphosphazene, (147) 144 Cytokines, (147) 342 Delivery, (147) 385 Dexamethasone phosphate, (147) 225 Diabetes, (147) 377 Direct translocation, (147) 171 Dissolution, (147) 232 Docetaxel, (147) 278 Dose sparing, (147) 326 Doxorubicin, (147) 428 Drug delivery, (147) 171, (147) 253, (147) 298, (147) 408, (147) 428, (147) 436 Drug distribution, (147) 92 Drug release, (147) 392 Drug targeting, (147) 136 Dual GF release, (147) 180 Dual growth factor delivery, (147) 193 Ectopic bone formation, (147) 38 Efflux pumps, (147) 62 Encapsulation efficiency, (147) 413 Endocytosis, (147) 261 Endotoxic shock, (147) 17 Enteric coatings, (147) 242 Enteric polymers, (147) 242 Erosion, (147) 70 Eye drop, (147) 76 Fibrin, (147) 24, (147) 180 Fibrosis, (147) 400 Fibrous capsule, (147) 400 Foreign body reaction, (147) 400 Formulation, (147) 211 Formulation pH, (147) 38
e12
Freeze drying, (147) 211 Fumaric acid monoethyl ester, (147) 54 Fusion protein, (147) 17 β-galactosidase, (147) 187 Gamma camera, (147) 253 Gamma scintigraphy, (147) 70, (147) 242 Gastric resistance, (147) 242 Gastrointestinal transit, (147) 242 Gelatin, (147) 269 Gene delivery, (147) 154, (147) 246 Gene silencing, (147) 101 Gemcitabine, (147) 163 Glycosaminoglycan, (147) 24 Gold nanoparticle, (147) 136 Heparin, (147) 420 Hepatitis B surface antigen, (147) 211 Human adipose-derived stem cell, (147) 84 Human growth hormone (hGH), (147) 359 Human serum albumin, (147) 17 Hyaluronan hydrogel, (147) 38 Hydrogel, (147) 377 Hydrogels, (147) 298 Hydroxyapatite, (147) 278 Hydroxypropylmethylcellulose (HPMC), (147) 70 Hyperthermia, (147) 436 Immune-response modifiers, (147) 342 Implant, (147) 400 In situ forming implant, (147) 350 In vivo drug release, (147) 350 In vivo visualisation, (147) 218 Influenza, (147) 326 Intracellular delivery, (147) 420 Intracellular uptake, (147) 261 In-vitro/in-vivo correlation (IVIVC), (147) 70 Labelling, (147) 92 Lactose intolerance, (147) 187 Ligand targeting, (147) 261 Lipid microspheres, (147) 202 Lipoplexes, (147) 385 Liposome, (147) 136 Liposomes, (147) 342 Local delivery, (147) 400 LRP, (147) 118 Macrophage, (147) 408 Mathematical modelling, (147) 232 Mesenchymal stem cells, (147) 154 Metabolization, (147) 163 Methacrylic acid ethyl acrylate copolymer, (147) 242 Micelle, (147) 144 Microneedle, (147) 326 Microneedles, (147) 218 Microparticles, (147) 187, (147) 377 Microsphere, (147) 45 Microspheres, (147) 92, (147) 342 Mouse model, (147) 342 MRI, (147) 232 mRNA, (147) 385 mTOR siRNA, (147) 400 Multiple-unit pellet system, (147) 2 MUPS, (147) 2 Myocardial infarction, (147) 30
Subject Index Volume 147 (2010)
NAcHis-GC, (147) 253 Nano-crystals, (147) 304 Nano-emulsion, (147) 304 Nanogel, (147) 420 Nanomedicine, (147) 408 Nanoparticle, (147) 163, (147) 278, (147) 304, (147) 408 Nanoparticles, (147) 342 Nanostructure, (147) 392 Near-infrared fluorescence, (147) 253 Nona-arginine, (147) 171 Non-invasive imaging, (147) 253 Non-ionic surfactant vesicles, (147) 127 N-vinyl-2-pyrrolidone, (147) 54 Ocular iontophoresis, (147) 225 Optical coherence tomography, (147) 333 Oral insulin, (147) 377 Oral peptide delivery, (147) 289 Osteoclast differentiation, (147) 45 Osteoporosis, (147) 45 Particle distribution, (147) 202 PDGF-BB, (147) 180 PEG, (147) 62, (147) 180 PEG-PLGA, (147) 92 PEI, (147) 62 Pellets, (147) 2 Peptidase inhibition, (147) 289 Peptide, (147) 392 Peptide modified nanocarrier, (147) 261 Percolation threshold, (147) 70 P-glycoprotein, (147) 62, (147) 118 Phagocytosis, (147) 408 Pharmacokinetic, (147) 17 Pharmacodynamic, (147) 17 Phase inversion, (147) 350 Phase transition, (147) 136 Phase-guided assembly, (147) 413 Phosphatidyloligoglycerol, (147) 436 Photo-crosslinking kinetics, (147) 54 Photodynamic therapy, (147) 368 pH-sensitive polymers, (147) 242 Physical cross-linking, (147) 298 Platinum drug, (147) 144 PLGA, (147) 187, (147) 193 PLGA microparticles, (147) 30 Pluronic, (147) 420 Pluronic F127, (147) 84 Pluronic-based nano-carriers, (147) 109 Poly(allyl)amine, (147) 289 Polycation, (147) 359 Polyelectrolyte complex (PEC), (147) 359 Polyethylene glycol, (147) 269 Polyethylene oxide, (147) 232 Polymeric micelle, (147) 76 Polymeric micelles, (147) 118 Polymeric microneedle arrays, (147) 333 Polymersome, (147) 413, (147) 428 Polyplexes, (147) 385 Poly(trimethylene carbonate), (147) 54 Pore formation, (147) 246 Primary human lung fibroblasts, (147) 127 Prostate cancer, (147) 278 Protein release, (147) 202 Pulmonary drug carrier, (147) 127 Pulsatile drug delivery, (147) 314
Subject Index Volume 147 (2010
Recumbinant albumin, (147) 17 Release mechanism, (147) 202 Resistance, (147) 163 RNase A, (147) 420 Salmon calcitonin, (147) 289 SAXS, (147) 136 Scaffold, (147) 392 Self-assembly, (147) 392 siRNA, (147) 101 Skin, (147) 326 Spinal cord, (147) 24 Spray drying, (147) 304 Squalenoylation, (147) 163 Stability, (147) 211 Stem cells, (147) 193 Stimuli, (147) 314 Subcellular localization, (147) 163 Sustained protein delivery, (147) 359 Tableting of pellets, (147) 2 Targeting, (147) 154, (147) 187 TGF-β1, (147) 180 TGF-β1 release, (147) 84 Thermoresponsive, (147) 298 Thermosensitive hydrogel, (147) 359 Thermosensitive liposomes, (147) 436
γ-thiobutyrolactone, (147) 62 Thiomers, (147) 62 Thioredoxin, (147) 17 Thrombolytic therapy, (147) 269 Timolol, (147) 225 t-PA, (147) 269 Transcutaneous, (147) 368 Transport, (147) 218 Trans-scleral, (147) 225 Tumor cell lines, (147) 246 Tumor targeting, (147) 109 Ultradeformable liposomes, (147) 368 Ultrasound, (147) 269, (147) 350 UV light, (147) 136 Vaccine delivery, (147) 342 Vancomycin, (147) 225 Vascular, (147) 180 VEGF, (147) 30 Vehicle, (147) 154 Vesicle, (147) 428 Vesicle size, (147) 436 Vinyl acetate, (147) 54 Virus-like particle vaccine, (147) 326 WGA, (147) 187
e13